期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胶体果胶铋联合左氧氟沙星三联疗法对慢性萎缩性胃炎患者血清PGⅠPGⅡ水平的影响 被引量：6

在线阅读 下载PDF
导出
摘要 目的探讨胶体果胶铋联合左氧氟沙星三联疗法对慢性萎缩性胃炎患者血清胃蛋白酶原Ⅰ(PGⅠ)、胃蛋白酶原Ⅱ(PGⅡ)水平的影响。方法将2018年1月-12月我科治疗的慢性萎缩性胃炎患者60例按随机数字表法分为对照组(n=30)和试验组(n=30),对照组采用左氧氟沙星片+克拉霉素+雷贝拉唑钠肠溶片三联疗法治疗,试验组则在对照组治疗的基础上给予胶体果胶铋胶囊,观察2组患者血清PGⅠ、PGⅡ水平。结果试验组血清PGⅠ、PGⅡ、PGⅠ/PGⅡ改善情况均优于对照组,且治疗效果优于对照组,差异具有统计学意义(P<0.05)。结论胶体果胶铋联合左氧氟沙星三联疗法治疗慢性萎缩性胃炎具有显著疗效,且可升高PGⅠ、PGⅠ/PGⅡ,降低PGⅡ,具有十分重要的临床价值。
作者 张宝东
机构地区 高邮市人民医院
出处 《基层医学论坛》 2019年第28期4047-4048,共2页 The Medical Forum
关键词 慢性萎缩性胃炎 三联疗法 胶体果胶铋 PGⅠ PGⅡ
分类号 R573.32 [医药卫生—消化系统]
  • 相关文献

参考文献4

二级参考文献49

  • 1Gisbert J P,Calvet X.Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori[].Alimentary Pharmacology and Therapeutics.2011
  • 2Jung Won Lee,Nayoung Kim,Jung Mogg Kim,Ryoung Hee Nam,Hyun Chang,Jae Yeon Kim,Cheol Min Shin,Young Soo Park,Dong Ho Lee,Hyun Chae Jung.Prevalence of Primary and Secondary Antimicrobial Resistance of H elicobacter pylori in K orea from 2003 through 2012[J].Helicobacter.2012(3)
  • 3Uemura N,Mukai T,Okamoto S,et al.Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer[].Cancer Epidemiology Biomarkers and Prevention.1997
  • 4Senkovich Olga A,Yin Jun,Ekshyyan Viktoriya,Conant Carolyn,Traylor James,Adegboyega Patrick,McGee David J,Rhoads Robert E,Slepenkov Sergey,Testerman Traci L.Helicobacter pylori AlpA and AlpB bind host laminin and influence gastric inflammation in gerbils[].Infection and Immunity.2011
  • 5Trinidad Parra Cid,Miryam Calvino Fernández,Selma Benito Martínez,Nicola L. Jones.Pathogenesis of H elicobacter pylori Infection[J].Helicobacter.2013
  • 6Victoria G Weis,Josane F Sousa,Bonnie J LaFleur,Ki Taek Nam,Jared A Weis,Paul E Finke,Nadia A Ameen,James G Fox,James R Goldenring.Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression[J].Gut.2013(9)
  • 7Ji Hyun Lim,Dong Ho Lee,Chiun Choi,Seong Tae Lee,Nayoung Kim,Sook Hyang Jeong,Jin Wook Kim,Jin Hyeok Hwang,Young Soo Park,Sang Hyub Lee,Cheol Min Shin,Hyun Jin Jo,Eun Sun Jang,In sung Song,Hyun Chae Jung.Clinical Outcomes of Two‐Week Sequential and Concomitant Therapies for Helicobacter pylori Eradication: A Randomized Pilot Study[J].Helicobacter.2013(3)
  • 8Wong BC,Lam SK,Wong WM,et al.Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China:a randomized controlled trial. The JAMA . 2004
  • 9Masatoshi Sakakibara,Takafumi Ando,Kazuhiro Ishiguro,Osamu Maeda,Osamu Watanabe,Yutaka Hirayama,Kazuhiro Morise,Keiko Maeda,Masanobu Matsushita,Kazuhiro Furukawa,Kohei Funasaka,Masanao Nakamura,Ryoji Miyahara,Hidemi Goto.Usefulness of H elicobacter pylori eradication for precancerous lesions of the gastric remnant[J]. J Gastroenterol Hepatol . 2014
  • 10Garrett Z. Ng,Yok‐Teng Chionh,Philip Sutton.Vaccine‐Mediated Protection against H elicobacter pylori is not Associated with Increased Salivary Cytokine or Mucin Expression[J]. Helicobacter . 2014 (1)

共引文献68

同被引文献68

引证文献6

二级引证文献18

基层医学论坛
2019年 第28期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部